MCKECHNIE DUNCAN (EVP, Chief Commercial Officer) received a stock award from VERTEX PHARMACEUTICALS INC / MA
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/19/2026ACC: 0000875320-26-000094
Officer· EVP, Chief Commercial Officer
Since Mar 2026
+3.81K
Net shares
Net buyer
$555.3K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
4.96K acquired · 1.15K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.96K
Price / share
—
Trade value
—
% of position
25.4%
2/17/2026
19.53K→24.49K
Common Stock
Direct
Shares
−1.15K
Price / share
$483.75
Trade value
$555.35K
% of position
4.7%
2/17/2026
24.49K→23.34K
Total
Net shares
+3.81K
Net value
-$555.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/17/2026 | A · Award | +4.96K | — | — | 25.4% | 19.53K | 24.49K |
| Common Stock Direct | 2/17/2026 | F · Tax Withholding | −1.15K | $483.75 | $555.35K | 4.7% | 24.49K | 23.34K |
| Total | +3.81K | -$555.35K | ||||||
Derivative Transactions0
No derivative transactions reported